Capabilities Presentation Stephen W. Gutkin, President 201 891 8205/8206 (o/f) 201 753 2962 (c) The Grace Building.

Slides:



Advertisements
Similar presentations
OVERVIEW OF FACULTY OF 1000’S SERVICES
Advertisements

A Generalised Model for Valuing Early Stage Technology Palisade Europe User Conference 2008 Michael Brand © 2008 Captum Capital Limited.
Project Quality Plans Gillian Sandilands Director of Quality
Mary Ellen Turner MD, MPH Vice-President
How to Explain Device Reimbursement to your CEO The Medical Device Regulatory and Compliance Congress Barbara J. Calvert March 29, 2006.
Professional Education Support Wyeth Pharmaceuticals Melinda Somasekhar, PhD.
Adis R&D Insight Sue Shoolbread Editorial Leader 12 June 2006.
SLA – Pipeline Town Hall Ben Weintraub and Jeff Southwood
UNM CTSC Mentored Career Development Scholars Program 6-Month Progress Report Template (Years 3+) Name Title Department or College.
ACME Marketing Plan Presented by Sydney Division [Slide 1]
Introduction to Medical Editing Build a freelance business or start a career as a professional medical editor  Medical & Biomedical Manuscripts  Editing.
WHO update on: Guidelines for the selection of RH medicines and prequalification of priority RH medicines Medicines Policy and Standards Health Technology.
HT Pharmaceuticals Clinical Research Consulting Humphrey Tebit, Principal.
1/16 Service Package for Life Science Start-Ups Regulatory, Reimbursement, Quality and Clinical Research In Europe and the USA UK Office: 27 Old Gloucester.
„Ensuring Regulatory and Pharmacovigilance Compliance“ „Ensuring Regulatory and Pharmacovigilance Compliance“
11 Securing the Future of Canada’s AHSCs… NATIONAL CONSULTATION FORUM Sheraton Hotel – Ottawa January 28 & 29, 2010 Dr. Nick Busing Co-chair, Steering.
Eli Lilly and Company – Tailored Therapeutics and Diagnostics © Eli Lilly and Company 2012 The views and opinions expressed herein and/or during the accompanying.
Sentient Medical Systems Health Tech Net Meeting December 14,
Alternative Careers in Pharma and Biotechnology Douglas Buckley Ph.D. May 13, 2011 Alternative Career Symposium Baylor College of Medicine.
From academia to medical communications Dr Annick Moon Medical communications consultant & writer.
Patti Peeples, RPh, PhD CEO and Founder CONNECTED. COMMUNITY. 1 st Inaugural Workshop More Effective.
Publication Planning: The Role of The Freelance Writer Tania Dickson, PhD Medical Director Carus Clinical Communications, an Elsevier business.
SWOT Case Study Johnson & Johnson Background  Johnson & Johnson formed in1886 and it released it’s product of note in 1896  The firm branched out in.
Reinventing Medical Education Marissa Seligman, PharmD VP & Compliance Officer Pri-Med Institute, Boston, MA June 7, 2005.
An introduction to Medical Communications
My Life in the Balance Fiona Steinkamp PhD Medical Writer Envision Pharma Ltd Horsham, West Sussex My Life in the Balance Fiona Steinkamp PhD Medical Writer.
Consulting for Life Sciences 1 Confidential October 14, 2014 Strategic Science and Technology Capabilities Discussion
Consulting Services Our core consulting services focus on government and commercial health programs from both sides: our provider-physicians and health.
Writing a Scientific Paper: Basics of Content and Organization
Careers in MCB: Medical Writing Paul Ferguson Senior Account Manager
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
Careers in Science Communication Robert A Jackson Lennard-Jones Laboratories, School of Physical & Geographical Sciences, Keele University, Keele, Staffs.
Your global support in Europe Over 20 years of experience ELM Pharmaceutica.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Slide 1 of 21 Nontraditional Careers in Chemistry at the ACS Nontraditional Careers in Chemistry at the American Chemical Society Lorrin R. Garson Robert.
Implementing Cochrane evidence via EBM Guidelines and EBMeDS Ilkka Kunnamo, MD, PhD Editor-in-Chief, EBM Guidelines & EBMeDS Adjunct Professor of General.
Different Types of Scientific Writing. Overview Different types of papers Types of reviews Organization of papers What to leave in; what to leave out.
CNESH: Top 10 Process ANDRA MORRISON 14 APRIL, 2015.
INTRODUCTION TO RA.
Applications of Computers in pharmacy
Clinical Pharmacy Part 2
Academy of Managed Care Pharmacy P4 student perspective Jina Park The Ohio State University PharmD Candidate 2014
MEDICAL experts INDUSTRY Some of our clients. Pharmaceutical companies, manufacturers of medical and surgical devices, clinical research organizations,
Case Study SummaryChallenges Boston Scientific needed medical translation in different areas in the medical field, including technical, legal and corporate.
ACCREDITED CONSULTANTS PVT LTD. (ACPL) WELCOMES YOU Your PHARMACOVIGILANCE PARTNER.
Francois Nader, MD, MBA Aventis June 6-9, 2004 Princeton, NJ The Pharma, Biotech and Device Colloquium Medical Affairs Organization Of The Future.
Which Journal to Publish in and How Barbara Gastel, MD, MPH Professor, Texas A&M University Knowledge Community Editor, AuthorAID.
Current Plan for Critical Path Initiative Janet Woodcock, M.D. Acting Deputy Commissioner For Operations November 5, 2004.
FDA Regulatory and Compliance Symposium Industry Collaboration & Interactions with Health Professionals: Can Conflicts of Interest be Properly Managed?
1 PRIORITY MEDICINES FOR EUROPE AND THE WORLD Barriers to Pharmaceutical Innovation Richard Laing EDM/PAR WHO.
FDA Draft Guidance Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved.
Teresa Esch, PhD Features Editor The Journal of Neuroscience
Global Clinical Trials Market Share, Global Trends, Analysis, Research, Report, Opportunities, Segmentation and Forecast,
Methodological and Statistical Considerations in Clinical Research Dr. Gloria Crispino, CStat CMath Copy Rights; Do not reproduce without authorization.
David J. Hauss, PhD, RPh Regeneron Pharmaceuticals, Inc. Tarrytown, NY.
Background  San Diego-based consulting company founded in 2001 by former Dura/Élan executives, with offices also located in the Boulder-Denver area 
Full-Service Collaborative Partnership Between a Pharmaceutical Company and a Vendor to Support Medical Information Services Amy L. Dixon, PharmD; Claudia.
How to Get Published: Surviving in the Academic World Stephen E. Condrey, Ph.D. Vice President, American Society for Public Administration Editor-in-Chief,
Christopher Tobias, PhD EVP, Chief Scientific Officer Dir., Business Development Dudnyk.
1 Promotion in Management and Research Tracks in Industry Magdalena Alonso-Galicia, PhD Cardiovascular Diseases Department Merck Research Laboratories.
Medical and Science Writing: No Post-doc Required
Recent Evolution of New Drug Review and Approval System in Korea
Clinical Study Results Publication
INTERNATIONAL CONFERENCE ON PHARMACEUTICAL RESEARCH AND DEVELOPMENT
Nutrition Information Credibility
PAI Preparation and Readiness
Nutrition Information & Credibility
All Professionals are involved in
Regulatory and timeline compliance
Presentation transcript:

Capabilities Presentation Stephen W. Gutkin, President /8206 (o/f) (c) The Grace Building 191 Godwin Ave. Suite 1 Wyckoff, NJ Biomedical Communications

Publication plan and execute. Lecture on medical writing (CBI, J&J). Coauthor 14 papers in peer-reviewed literature. Stephen W. Gutkin Professional timeline Present Serve as research scientist in commercial toxicology laboratory. Serve as editorial manager: McGraw-Hill, Raven Press, HLS. Incorporate Rete Com. Review 100s of CVs to obtain select group of PhD/MD/ELS writers/editors (rete= network). Develop editorial acumen to inform development of elaborate QC systems.

Support publication of 148 papers in peer- reviewed journals within the past 12 years. Collaborate with 435 researchers: 295 academicians and 140 pharmaceutical professionals. Highlighted achievements Launch and commercialize best-in-class medications. Cultivate relationships with 4 of the Top 10 pharmaceutical companies by market capitalization. (2 of these relationships exceed 10 years.)

Rete geometry: squaring the circle: Our stakeholders and our promise * Journal/peer reviewers Author/KOL Pharma/device/ diagnostics or other grantor * Top-notch, authoritative, credible, and fair-balanced communications that meet client needs; on-time deliverables; competitive prices. RETE

Urology/mens health KOL: Best medical writer Ive ever worked with. Peer reviewer of prestigious IM journal: [When published] this will become the best review of the topic in the entire peer-reviewed literature. Journal editors/peer reviewers: It is always a pleasure to read Stephen Gutkins prose. As would be expected from a Gutkin manuscript, a well-presented study. As always, I really appreciate all the work you put into making these papers run so smoothly. Recent testimonials

Fulfilling the promise Rete (L.) = network Rete Com = electronic network of medical-communications professionals. Top-notch consultants: scientific researchers and managers. Superior quality of work assured via internal implementation of rigorous QC systems and editorial standards based on consensus guidelines for manuscript preparation.

Person-years Editorial expertise (n = 12)(n = 8)(n = 20)

Fair balance: Coin of our realm in publications

Medical communications across the product life cycle Preclinical Phase I Phase II Phase III/Launch Mature product Study reports Regulatory documents Protocol CSR ISS/ISE AMCP drug dossier Journal supplement Pharmacoepidemiologic study report Pivotal and other clinical study reports Product monograph Sales training Stage-setting review CME Data mining Outcomes research Pharmacoeconomic analyses Post-marketing surveillance (pharmacovigilance) Abstracts, Posters, Slide-lecture kits, Review articles

Summary Stephen W. Gutkin = medical-communications professional with 27 years of experience as a medical writer and editorial manager. Rete Com = network of savvy scientific professionals producing credible, fair-balanced medical communications. Meeting the needs of KOLs, pharma/device grantors, journals, policymakers/reimbursement authorities, FDA, professional societies, and MD readers. Strengths include vascular medicine and neuroscience. Media and venues include publications, posters, abstracts, and documents for regulatory and reimbursement authorities.